SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

S Pather, SA Madhi, BJ Cowling, P Moss… - Frontiers in …, 2023 - frontiersin.org
The highly transmissible Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were …

SARS-CoV-2 infection in children and implications for vaccination

J Nathanielsz, ZQ Toh, LAH Do, K Mulholland… - Pediatric …, 2023 - nature.com
The COVID-19 pandemic caused by novel severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) is responsible for more than 500 million cases worldwide as of April 2022 …

[HTML][HTML] Modeling transmission of SARS-CoV-2 omicron in China

J Cai, X Deng, J Yang, K Sun, H Liu, Z Chen, C Peng… - Nature medicine, 2022 - nature.com
Having adopted a dynamic zero-COVID strategy to respond to SARS-CoV-2 variants with
higher transmissibility since August 2021, China is now considering whether, and for how …

Association of semaglutide with risk of suicidal ideation in a real-world cohort

W Wang, ND Volkow, NA Berger, PB Davis… - Nature medicine, 2024 - nature.com
Concerns over reports of suicidal ideation associated with semaglutide treatment, a
glucagon-like peptide 1 receptor (GLP1R) agonist medication for type 2 diabetes (T2DM) …

Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US

S Flaxman, C Whittaker, E Semenova… - JAMA network …, 2023 - jamanetwork.com
Importance COVID-19 was the underlying cause of death for more than 940 000 individuals
in the US, including at least 1289 children and young people (CYP) aged 0 to 19 years, with …

Association of COVID-19 with new-onset Alzheimer's disease

L Wang, PB Davis, ND Volkow… - Journal of …, 2022 - content.iospress.com
An infectious etiology of Alzheimer's disease has been postulated for decades. It remains
unknown whether SARS-CoV-2 viral infection is associated with increased risk for …

Severe COVID-19 outcomes in pediatrics: An observational cohort analysis comparing Alpha, Delta, and Omicron variants

A Bahl, N Mielke, S Johnson, A Desai… - The Lancet Regional …, 2023 - thelancet.com
Objective COVID-19 can rarely lead to severe illness in pediatric patients. The aim of this
study was to determine if severe outcomes in pediatric COVID-19 have changed over the …

Risk factors for multisystem inflammatory syndrome in children–A population-based cohort study of over 2 million children

S Rhedin, C Lundholm, AC Horne, AI Smew… - The Lancet Regional …, 2022 - thelancet.com
Background Although severe acute COVID-19 is rare in children, SARS-CoV-2 infection can
trigger the novel post-infectious condition multisystem inflammatory syndrome in children …

Pediatric hospitalizations and ICU admissions due to COVID-19 and pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 in England

JL Ward, R Harwood, S Kenny, J Cruz, M Clark… - JAMA …, 2023 - jamanetwork.com
Importance Investigating how the risk of serious illness after SARS-CoV-2 infection in
children and adolescents has changed as new variants have emerged is essential to inform …

[HTML][HTML] Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0–5 years in the USA in 2022: a multicentre retrospective cohort …

L Wang, PB Davis, N Berger, DC Kaelber… - Family medicine and …, 2023 - ncbi.nlm.nih.gov
Objective To investigate whether COVID-19 infection was associated with increased risk for
incident respiratory syncytial virus (RSV) infections and associated diseases among young …